Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 8 Issue 6, June 2008

From The Editors

Top of page ⤴

Research Highlight

Top of page ⤴

Trial Watch

Top of page ⤴

Research Highlight

Top of page ⤴

In the News

Top of page ⤴

Research Highlight

Top of page ⤴

In Brief

Top of page ⤴

Research Highlight

Top of page ⤴

Review Article

  • Recent advances in our understanding of intestinal crypt biology, including how mutations in stem cells become fixed and expand within the epithelium, has led to new theories on the origins of colonic adenomas and cancers.

    • Adam Humphries
    • Nicholas A. Wright
    Review Article
  • Hypoxia and free radicals, such as reactive oxygen and nitrogen species, alter the activity of the transcription factor HIF1, which can regulate tumour cell survival and angiogenesis. Intratumoural heterogeneity of these factors significantly affects HIF1 and consequently the response to cytotoxic therapy.

    • Mark W. Dewhirst
    • Yiting Cao
    • Benjamin Moeller
    Review Article
Top of page ⤴

Innovation

  • The Mouse Tumor Biology database seeks to facilitate the researcher's access to the ever increasing amount of data now being published using mouse models of cancer. Why is this database important and how does it relate to similar databases within the cancer research community?

    • Debra M. Krupke
    • Dale A. Begley
    • Janan T. Eppig
    Innovation
Top of page ⤴

Science and Society

  • The next generation of space missions will involve much longer exposures of astronauts to space radiation. Predicting what this means for cancer risk is a crucial but difficult task.

    • Marco Durante
    • Francis A. Cucinotta
    Science and Society
Top of page ⤴

Timeline

  • One hundred years ago, Paul Ehrlich received the Nobel Prize for Physiology or Medicine. His idea of creating 'magic bullets' for use in the fight against human diseases has inspired generations of scientists to devise powerful molecular cancer therapeutics.

    • Klaus Strebhardt
    • Axel Ullrich
    Timeline
Top of page ⤴

Search

Quick links